Our Perspective

We recognize the significant role that social media plays in the lives of the people and communities we serve. Our presence on social media channels provides us a unique opportunity to interact with and be responsive to patients, families, healthcare professionals, employees, investors, and other interested persons. We are committed to interacting with all stakeholders legally, ethically and in accordance with regulatory standards.

We welcome and encourage your participation and engagement. When you engage with us on social media, you also agree to abide by the following Social Media Community Guidelines, which apply in addition to the Terms and Conditions or other legal notices specific to each social media channel.

There are certain topics we are not able or willing to discuss on social media channels. Specifically, we will not:

  • Offer medical advice, whether related to our approved or investigational products or our disease states of interest. An individual’s healthcare provider is the best resource for questions about their health. We may share information about medical or health topics, which should not be construed as medical advice, but rather educational content presented solely for informational purposes.
  • Respond to adverse event reports and/or product complaints, and any such replies or comments will be deleted, as social media is not the appropriate forum for these kinds of reports. If you have experienced an adverse event or think you may be experiencing an adverse event, you should seek advice from a healthcare professional. If you wish to report an adverse event or product complaint about a Actelion Pharmaceuticals Deutschland GmbHproduct, please contact us at (877) 361-2719. If you do post about an adverse event on our social media channels, we will follow-up and report the event.
  • Discuss usge of Actelion Pharmaceuticals Deutschland GmbHproducts or products of other pharmaceutical . Any questions or comments about specific products should be made to your healthcare professional.
  • Discuss or respond to comments about Actelion Pharmaceuticals Deutschland GmbH's corporate performance, partnerships, litigation or business operations.

The following types of comments and replies are not acceptable, and we reserve the right to delete those that:

  • use profane, defamatory, libelous, offensive, hateful, or demeaning language, video, images or other media;
  • Are disparaging or threatening, to Actelion Pharmaceuticals Deutschland GmbH, other , or individuals;
  • Promote illegal activity;
  • Discuss religious or politically divisive subjects;
  • Are misleading, fraudulent, or deceptive;
  • Provide medical advice of any kind, including through links to third party content or websites;
  • Are related to the use of any of Actelion Pharmaceuticals Deutschland GmbH's approved or investigational products (including adverse events and product complaints);
  • Contain proprietary, confidential, sensitive or non-public information about, or related to, Actelion Pharmaceuticals Deutschland GmbH, other or individuals;
  • Contain personal and/or identifying information about individuals (including the person who replies or comments);
  • Are promotional, solicitous or constitute advertising for other products or services;
  • Are excessively repetitive, SPAM or bot-like in nature or otherwise disruptive to the community;
  • Contain links, images, videos, or other media not owned by Actelion Pharmaceuticals Deutschland GmbH.

We reserve the right to remove any comments that include such materials, and we may block or remove any user who does not comply with these Community Guidelines. There may be additional scenarios not outlined above that lead to the removal of comments or blocking of users and Actelion Pharmaceuticals Deutschland GmbHreserves the right to remove comments or block users at its reasonable discretion.

Responses to individual users do not imply endorsement of posts. Actelion Pharmaceuticals Deutschland GmbHdoes not endorse and is not responsible for information and opinions shared by social media users.

We may occasionally share links to third-party sites when we feel that the information is relevant or helpful. However, this does not in any way constitute an official endorsement of the author, website, or company who owns the website or the information on that website. Actelion Pharmaceuticals Deutschland GmbHis not responsible for content posted by third parties.

Please note that third-party social media channels also have access to information you share via social media. For more details, read their Privacy Policy. For additional information about privacy at Actelion Pharmaceuticals Deutschland GmbH, please see our Privacy Policy and Legal Notice.

Neither Actelion Pharmaceuticals Deutschland GmbHnor our content providers shall be liable for any damages or injury arising out of your access to, or inability to access our social media channels, or from your reliance on any information provided therein. We disclaim any and all liability for direct, indirect, incidental, consequential, punitive, and special or other damages, lost opportunities, lost profit or any other loss or damage of any kind. This limitation includes damages or any viruses, malware, or ransomware, which may affect your computer or mobile device.

Actelion Pharmaceuticals Deutschland GmbHreserves the right to update these Social Media Community Guidelines at any time in its sole discretion.

Last updated 08/30/2022